Paradigm Biocapital Advisors LP

13F Holdings History for Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (LXEO)

Symbol
LXEO on Nasdaq
Investment type
Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership
3.67M shares
Security Ownership
5%

Paradigm BioCapital Advisors LP ownership in Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share (LXEO)

2025-11-20 - Paradigm BioCapital Advisors LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.67M shares of Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share (LXEO). This represents 5% percent ownership of the company.